A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

NCT05716100 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Focal Onset Seizures

Interventions

DRUG: XEN1101
DRUG: Placebo

Sponsor

Xenon Pharmaceuticals Inc.

Collaborators

[object Object]